nodes	percent_of_prediction	percent_of_DWPC	metapath
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0316	0.035	CbGpPWpGaD
Tropicamide—CHRM4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.027	0.0298	CbGpPWpGaD
Tropicamide—CHRM4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0262	0.0289	CbGpPWpGaD
Tropicamide—CHRM4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0244	0.027	CbGpPWpGaD
Tropicamide—CHRM4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0227	0.0251	CbGpPWpGaD
Tropicamide—CHRM4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.022	0.0243	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0213	0.0236	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0213	0.0235	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.021	0.0233	CbGpPWpGaD
Tropicamide—CHRM4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0205	0.0227	CbGpPWpGaD
Tropicamide—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0182	0.0201	CbGpPWpGaD
Tropicamide—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0181	0.02	CbGpPWpGaD
Tropicamide—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0179	0.0198	CbGpPWpGaD
Tropicamide—Modafinil—SLC6A3—Gilles de la Tourette syndrome	0.0177	0.536	CrCbGaD
Tropicamide—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0177	0.0195	CbGpPWpGaD
Tropicamide—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0176	0.0195	CbGpPWpGaD
Tropicamide—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0174	0.0193	CbGpPWpGaD
Tropicamide—CHRM4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0171	0.0189	CbGpPWpGaD
Tropicamide—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0164	0.0182	CbGpPWpGaD
Tropicamide—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0164	0.0181	CbGpPWpGaD
Tropicamide—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0162	0.0179	CbGpPWpGaD
Tropicamide—Benzphetamine—SLC6A3—Gilles de la Tourette syndrome	0.0153	0.464	CrCbGaD
Tropicamide—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0153	0.0169	CbGpPWpGaD
Tropicamide—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0152	0.0168	CbGpPWpGaD
Tropicamide—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0151	0.0167	CbGpPWpGaD
Tropicamide—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0148	0.0164	CbGpPWpGaD
Tropicamide—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0148	0.0164	CbGpPWpGaD
Tropicamide—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0146	0.0162	CbGpPWpGaD
Tropicamide—CHRM4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0144	0.0159	CbGpPWpGaD
Tropicamide—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0138	0.0153	CbGpPWpGaD
Tropicamide—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0138	0.0152	CbGpPWpGaD
Tropicamide—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0136	0.0151	CbGpPWpGaD
Tropicamide—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0115	0.0127	CbGpPWpGaD
Tropicamide—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0115	0.0127	CbGpPWpGaD
Tropicamide—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0114	0.0126	CbGpPWpGaD
Tropicamide—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00968	0.0107	CbGpPWpGaD
Tropicamide—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00965	0.0107	CbGpPWpGaD
Tropicamide—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00956	0.0106	CbGpPWpGaD
Tropicamide—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00931	0.149	CbGeAlD
Tropicamide—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00896	0.143	CbGeAlD
Tropicamide—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00805	0.0089	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00797	0.00881	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00782	0.00864	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00774	0.00856	CbGpPWpGaD
Tropicamide—CHRM4—brain—Gilles de la Tourette syndrome	0.00711	0.114	CbGeAlD
Tropicamide—CHRM4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00561	0.0062	CbGpPWpGaD
Tropicamide—CHRM4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00544	0.00602	CbGpPWpGaD
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0052	0.00575	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0051	0.00564	CbGpPWpGaD
Tropicamide—CHRM4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00507	0.00561	CbGpPWpGaD
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00505	0.00559	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00505	0.00558	CbGpPWpGaD
Tropicamide—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00499	0.0799	CbGeAlD
Tropicamide—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00481	0.0769	CbGeAlD
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00471	0.0052	CbGpPWpGaD
Tropicamide—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00455	0.0727	CbGeAlD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00446	0.00493	CbGpPWpGaD
Tropicamide—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.00438	0.07	CbGeAlD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00433	0.00479	CbGpPWpGaD
Tropicamide—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00428	0.00474	CbGpPWpGaD
Tropicamide—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00416	0.0046	CbGpPWpGaD
Tropicamide—CHRM3—nervous system—Gilles de la Tourette syndrome	0.00407	0.0651	CbGeAlD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00403	0.00446	CbGpPWpGaD
Tropicamide—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00392	0.0627	CbGeAlD
Tropicamide—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00387	0.00428	CbGpPWpGaD
Tropicamide—CHRM2—brain—Gilles de la Tourette syndrome	0.00382	0.0611	CbGeAlD
Tropicamide—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00373	0.00413	CbGpPWpGaD
Tropicamide—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00362	0.00401	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00351	0.00388	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0035	0.00387	CbGpPWpGaD
Tropicamide—CHRM1—brain—Gilles de la Tourette syndrome	0.00347	0.0556	CbGeAlD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00346	0.00383	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00341	0.00377	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0034	0.00375	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0034	0.00375	CbGpPWpGaD
Tropicamide—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00338	0.00373	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00336	0.00372	CbGpPWpGaD
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0033	0.00364	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0033	0.00364	CbGpPWpGaD
Tropicamide—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00328	0.00363	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00317	0.00351	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00316	0.0035	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00313	0.00346	CbGpPWpGaD
Tropicamide—CHRM3—brain—Gilles de la Tourette syndrome	0.00311	0.0498	CbGeAlD
Tropicamide—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00307	0.00339	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00301	0.00332	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.003	0.00331	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00297	0.00328	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00292	0.00323	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00291	0.00322	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00288	0.00318	CbGpPWpGaD
Tropicamide—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00288	0.00318	CbGpPWpGaD
Tropicamide—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00287	0.00317	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00282	0.00312	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00272	0.00301	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00271	0.003	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00268	0.00297	CbGpPWpGaD
Tropicamide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00257	0.00284	CbGpPWpGaD
Tropicamide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00256	0.00283	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00229	0.00253	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00228	0.00252	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00226	0.0025	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00222	0.00246	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00222	0.00246	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00222	0.00245	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00222	0.00245	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00219	0.00243	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00219	0.00243	CbGpPWpGaD
Tropicamide—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00219	0.00242	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00215	0.00238	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00207	0.00229	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00206	0.00228	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00204	0.00226	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00192	0.00212	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0019	0.00211	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0019	0.0021	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00188	0.00208	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00186	0.00206	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00174	0.00193	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00174	0.00192	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00169	0.00187	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00158	0.00174	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00145	0.0016	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00145	0.0016	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00158	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00129	0.00143	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00129	0.00143	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00128	0.00141	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00126	0.00139	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00125	0.00138	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00124	0.00137	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00122	0.00134	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00117	0.0013	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00117	0.00129	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00117	0.00129	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00117	0.00129	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00116	0.00128	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00115	0.00128	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00114	0.00126	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00114	0.00126	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00113	0.00124	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0011	0.00122	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00106	0.00117	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00106	0.00117	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00105	0.00116	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00103	0.00114	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000999	0.0011	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000931	0.00103	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000819	0.000906	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000817	0.000903	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000809	0.000894	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000744	0.000823	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000742	0.00082	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000735	0.000812	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000694	0.000767	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000692	0.000765	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000685	0.000757	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000674	0.000745	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000672	0.000742	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000665	0.000735	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000652	0.000721	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000628	0.000694	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000626	0.000692	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00062	0.000685	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00044	0.000486	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000438	0.000484	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000434	0.00048	CbGpPWpGaD
